The Healing Effects of Human Acellular Amniotic Membrane on Skin Wound in Diabetic Animals

Document Type : Original paper

Authors

1 Skin and Stem Cell Research Center, Tehran University of Medical Sciences, Tehran, Iran

2 Department of Biology, Faculty of Basic Sciences, East Tehran Branch, Islamic Azad University, Tehran, Iran

Abstract

Background and aim: Human amniotic membrane has been used as a versatile skin alternative in dermatology as an ideal biological dressing material. It has been reported to have wound healing effects, however, the findings still are challenging. The aim of this study was to investigate the healing effects of acellular human amniotic membrane on skin wound healing in diabetic rats. Materials and methods: Acellular amnion membrane was prepared using DMSO and characterized by electron microscopy. Rats were divide into control (without treatment) and experiment (treatment with acellular amniotic membrane) groups (n=5 in each group). Diabetes was induced in animals by intraperitoneal injection of streptozotocin (150 mg/kg), and a full[1]thickness skin defect model was generated. Wound healing was evaluated 7, 14 and days after treatment using Image J software. Results: Significant decrease in wound area was observed 7, 14 and 21 days after treatment in experiment rats compared with control animals. The was also significant difference between wound area at 7, 14 and 21 days after treatment. Conclusion: Our findings indicated that acellular human amniotic membrane has a significant wound healing potential, accelerating the wound healing process in diabetic subjects.

Keywords

References

[1]. Blair M. Diabetes mellitus review. Urologic nursing. 2016;36(1).
[2]. Olokoba AB, Obateru OA, Olokoba LB. Type 2 diabetes mellitus: a review of current trends. Oman medical journal. 2012;27(4):269.
[3]. Clayton Jr W, Elasy TA. A review of the pathophysiology, classification, and treatment of foot ulcers in diabetic patients. Clinical diabetes. 2009;27(2):52-8.
[4]. Leung PC. Diabetic foot ulcers—a comprehensive review. The Surgeon. 2007;5(4):219-31.
[5]. Tang K, Wu J, Xiong Z, Ji Y, Sun T, Guo X. Human acellular amniotic membrane: A potential osteoinductive biomaterial for bone regeneration. J Biomater Appl. 2018;32(6):754-764.
[6]. Pan SY, Chan MK, Wong MB, Klokol D, Chernykh V. Placental therapy: An insight to their biological and therapeutic properties. blood. 2017;4(11):12.
[7]. Parolini O, Solomon A, Evangelista M, Soncini M. Human term placenta as a therapeutic agent: from the first clinical applications to future perspectives. 2010;1-48.
[8]. Anselmo DS, McGuire JB, Love E, Vlahovic T. Application of Viable Cryopreserved Human Placental Membrane Grafts in the Treatment of Wounds of Diverse Etiologies: A Case Series. Wounds: a Compendium of Clinical Research and Practice. 2018;30(3):57-61.
[9]. Glat P, Orgill DP, Galiano R, Armstrong D, Serena T, DiDomenico LA, Kaufman J, Carter MJ, Jacobs AM, Zelen CM. Placental membrane provides improved healing efficacy and lower cost versus a tissue-engineered human skin in the treatment of diabetic foot ulcerations. Plastic and Reconstructive Surgery Global Open. 2019;7(8).
[10]. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes research and clinical practice. 2010;87(1):4-14.
[11]. Mahmood R, Choudhery MS, Mehmood A, Khan SN, Riazuddin S. In vitro differentiation potential of human placenta derived cells into skin cells. Stem cells international. 2015;2015.
[12]. Faulk WP, Stevens P, Burgos H, Matthews R, Bennett J, Hsi BL. Human amnion as an adjunct in wound healing. The Lancet. 1980;315(8179):1156-8.
[13]. Werber B, Martin E. A prospective study of 20 foot and ankle wounds treated with cryopreserved amniotic membrane and fluid allograft. The Journal of Foot and Ankle Surgery. 2013;52(5):615-21.
[14]. Maxson S, Lopez EA, Yoo D, Danilkovitch-Miagkova A, LeRoux MA. Concise review: role of mesenchymal stem cells in wound repair. Stem cells translational medicine. 2012;1(2):142-9.
[15]. Luck J, Rodi T, Geierlehner A, Mosahebi A. Allogeneic skin substitutes versus human placental membrane products in the management of diabetic foot ulcers: a narrative comparative evaluation of the literature. The International Journal of Lower Extremity Wounds. 2019;18(1):10-22.
[16]. Ananian CE, Dhillon YS, Van Gils CC, Lindsey DC, Otto RJ, Dove CR, Pierce JT, Saunders MC. A multicenter, randomized, single‐blind trial comparing the efficacy of viable cryopreserved placental membrane to human fibroblast‐derived dermal substitute for the treatment of chronic diabetic foot ulcers. Wound Repair and Regeneration .2018;26(3):274-83.
[17]. Lobo Gajiwala A, Sharma V. Use of irradiated amnion as a biological dressing in the treatment of radiation induced ulcers. Cell and Tissue Banking. 2003;4(2):147-50.
[18]. Maral T, Borman H, Arslan H, Demirhan B, Akinbingol G, Haberal M. Effectiveness of human amnion preserved long-term in glycerol as a temporary biological dressing. Burns.1999;25(7):625-35.
[19]. Mohammadi AA, Jafari SM, Kiasat M, Tavakkolian AR, Imani MT, Ayaz M, Tolide-ie HR. Effect of fresh human amniotic membrane dressing on graft take in patients with chronic burn wounds compared with conventional methods. Burns. 2013;39(2):349-53.
[20]. Choi JA, Jin HJ, Jung S, Yang E, Choi JS, Chung SH, Joo CK. Effects of amniotic membrane suspension in human corneal wound healing in vitro. 2009.
[21]. Singh R, Chouhan US, Purohit S, Gupta P, Kumar P, Kumar A, Chacharkar MP, Kachhawa D, Ghiya BC. Radiation processed amniotic membranes in the treatment of non-healing ulcers of different etiologies. Cell and Tissue Banking. 2004;5(2):129-34.
[22]. Arai N, Tsuno H, Okabe M, Yoshida T, Koike C, Noguchi M, Nikaido T. Clinical application of a hyperdry amniotic membrane on surgical defects of the oral mucosa. Journal of Oral and Maxillofacial Surgery. 2012 Sep 1;70(9):2221-8.
[23]. Raspovic KM, Wukich DK, Naiman DQ, Lavery LA, Kirsner RS, Kim PJ, Steinberg JS, Attinger CE, Danilkovitch A. Effectiveness of viable cryopreserved placental membranes for management of diabetic foot ulcers in a real world setting. Wound Repair and Regeneration. 2018 Mar;26(2):213-20.
[24]. Zelen CM, Serena TE, Fetterolf DE. Dehydrated human amnion/chorion membrane allografts in patients with chronic diabetic foot ulcers: a long-term follow-up study. Wound Medicine. 2014;4:1-4.
[25]. Parks VE, Banks J, Johnson L, Liette MD, Crisologo P, Lavery LA. 601-P: a meta-analysis of clinical effectiveness of amnion tissue products in the management of diabetic foot ulcers. Diabetes. 2020;69(Supplement_1).
[26]. Lakmal K, Basnayake O, Hettiarachchi D. Systematic review on the rational use of amniotic membrane allografts in diabetic foot ulcer treatment. BMC surgery. 2021;21(1):1-8
International Journal of BioLife Sciences (IJBLS)
Volume 1, Issue 3
(Special Issue: papers selected from ICLS22, Istanbul, Turkey)
Pages 159-164

Files

History

  • Receive Date: 11 September 2022
  • Revise Date: 15 September 2022
  • Accept Date: 05 October 2022

Share

How to cite

Statistics